Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment

L. G. Ekali, L. K. Johnstone, Justin Echouffo Tcheugui, C. Kouanfack, M. Y. Dehayem, L. Fezeu, B. Nouthe, L. Hayes, N. C. Unwin, E. Sobngwi

Research output: Contribution to journalArticle

Abstract

Aims: This study assessed the relationship between highly active antiretroviral therapy (HAART) duration and cardiometabolic disorders in HIV-infected Cameroonians. Methods: HIV-infected Cameroonians aged 21 years or above were cross-sectionally recruited at the Yaoundé Central Hospital, a certified HIV care centre, and their anthropometry, body composition (impedancemetry), fasting blood glucose (FBG) and lipid levels, and insulin sensitivity (IS; short insulin tolerance test) were measured. Results: A total of 143 participants with various durations of HAART [treatment-naïve (n= 28), 1-13 months (n= 44), 14-33 months (n= 35) and 34-86 months (n= 36)] were recruited. They were mostly women (72%), and had a mean age of 39.5 (SD: 9.8) years. Half (52%) were using a stavudine-containing regimen. There was a significant trend towards a positive change in body mass index and waist-to-hip ratio with increasing duration of HAART (all P= 0.02). Systolic (P= 0.04) and diastolic (P= 0.03) blood pressure, total cholesterol (P= 0.01), prevalence of hypertension (P= 0.04) and hypercholesterolaemia (P= 0.007) were also significantly increased with HAART duration, whereas triglycerides, FBG and IS were unaffected. Clustering of metabolic disorders increased (P= 0.02 for ≥ 1 component of the metabolic syndrome and P= 0.09 for ≥ 2 components) with HAART duration. Conclusion: HAART duration is associated with obesity, fat distribution, blood pressure and cholesterol levels in HIV-infected Cameroonians, but does not appear to significantly affect glucose metabolism.

Original languageEnglish (US)
Pages (from-to)71-77
Number of pages7
JournalDiabetes and Metabolism
Volume39
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Highly Active Antiretroviral Therapy
Insulin Resistance
Blood Glucose
Fasting
HIV
Therapeutics
Cholesterol
Blood Pressure
Stavudine
Anthropometry
Waist-Hip Ratio
Body Composition
Hypercholesterolemia
Cluster Analysis
Triglycerides
Body Mass Index
Obesity
Fats
Insulin
Hypertension

Keywords

  • Antiretroviral therapy
  • Cardiovascular risk factors
  • Human immunodeficiency virus
  • Hyperglycaemia
  • Insulin sensitivity

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment. / Ekali, L. G.; Johnstone, L. K.; Echouffo Tcheugui, Justin; Kouanfack, C.; Dehayem, M. Y.; Fezeu, L.; Nouthe, B.; Hayes, L.; Unwin, N. C.; Sobngwi, E.

In: Diabetes and Metabolism, Vol. 39, No. 1, 01.01.2013, p. 71-77.

Research output: Contribution to journalArticle

Ekali, L. G. ; Johnstone, L. K. ; Echouffo Tcheugui, Justin ; Kouanfack, C. ; Dehayem, M. Y. ; Fezeu, L. ; Nouthe, B. ; Hayes, L. ; Unwin, N. C. ; Sobngwi, E. / Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment. In: Diabetes and Metabolism. 2013 ; Vol. 39, No. 1. pp. 71-77.
@article{1dd1d691ed0d4effa84cf2b02469f4b5,
title = "Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment",
abstract = "Aims: This study assessed the relationship between highly active antiretroviral therapy (HAART) duration and cardiometabolic disorders in HIV-infected Cameroonians. Methods: HIV-infected Cameroonians aged 21 years or above were cross-sectionally recruited at the Yaound{\'e} Central Hospital, a certified HIV care centre, and their anthropometry, body composition (impedancemetry), fasting blood glucose (FBG) and lipid levels, and insulin sensitivity (IS; short insulin tolerance test) were measured. Results: A total of 143 participants with various durations of HAART [treatment-na{\"i}ve (n= 28), 1-13 months (n= 44), 14-33 months (n= 35) and 34-86 months (n= 36)] were recruited. They were mostly women (72{\%}), and had a mean age of 39.5 (SD: 9.8) years. Half (52{\%}) were using a stavudine-containing regimen. There was a significant trend towards a positive change in body mass index and waist-to-hip ratio with increasing duration of HAART (all P= 0.02). Systolic (P= 0.04) and diastolic (P= 0.03) blood pressure, total cholesterol (P= 0.01), prevalence of hypertension (P= 0.04) and hypercholesterolaemia (P= 0.007) were also significantly increased with HAART duration, whereas triglycerides, FBG and IS were unaffected. Clustering of metabolic disorders increased (P= 0.02 for ≥ 1 component of the metabolic syndrome and P= 0.09 for ≥ 2 components) with HAART duration. Conclusion: HAART duration is associated with obesity, fat distribution, blood pressure and cholesterol levels in HIV-infected Cameroonians, but does not appear to significantly affect glucose metabolism.",
keywords = "Antiretroviral therapy, Cardiovascular risk factors, Human immunodeficiency virus, Hyperglycaemia, Insulin sensitivity",
author = "Ekali, {L. G.} and Johnstone, {L. K.} and {Echouffo Tcheugui}, Justin and C. Kouanfack and Dehayem, {M. Y.} and L. Fezeu and B. Nouthe and L. Hayes and Unwin, {N. C.} and E. Sobngwi",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.diabet.2012.08.012",
language = "English (US)",
volume = "39",
pages = "71--77",
journal = "Diabetes and Metabolism",
issn = "1262-3636",
publisher = "Elsevier Masson",
number = "1",

}

TY - JOUR

T1 - Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment

AU - Ekali, L. G.

AU - Johnstone, L. K.

AU - Echouffo Tcheugui, Justin

AU - Kouanfack, C.

AU - Dehayem, M. Y.

AU - Fezeu, L.

AU - Nouthe, B.

AU - Hayes, L.

AU - Unwin, N. C.

AU - Sobngwi, E.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Aims: This study assessed the relationship between highly active antiretroviral therapy (HAART) duration and cardiometabolic disorders in HIV-infected Cameroonians. Methods: HIV-infected Cameroonians aged 21 years or above were cross-sectionally recruited at the Yaoundé Central Hospital, a certified HIV care centre, and their anthropometry, body composition (impedancemetry), fasting blood glucose (FBG) and lipid levels, and insulin sensitivity (IS; short insulin tolerance test) were measured. Results: A total of 143 participants with various durations of HAART [treatment-naïve (n= 28), 1-13 months (n= 44), 14-33 months (n= 35) and 34-86 months (n= 36)] were recruited. They were mostly women (72%), and had a mean age of 39.5 (SD: 9.8) years. Half (52%) were using a stavudine-containing regimen. There was a significant trend towards a positive change in body mass index and waist-to-hip ratio with increasing duration of HAART (all P= 0.02). Systolic (P= 0.04) and diastolic (P= 0.03) blood pressure, total cholesterol (P= 0.01), prevalence of hypertension (P= 0.04) and hypercholesterolaemia (P= 0.007) were also significantly increased with HAART duration, whereas triglycerides, FBG and IS were unaffected. Clustering of metabolic disorders increased (P= 0.02 for ≥ 1 component of the metabolic syndrome and P= 0.09 for ≥ 2 components) with HAART duration. Conclusion: HAART duration is associated with obesity, fat distribution, blood pressure and cholesterol levels in HIV-infected Cameroonians, but does not appear to significantly affect glucose metabolism.

AB - Aims: This study assessed the relationship between highly active antiretroviral therapy (HAART) duration and cardiometabolic disorders in HIV-infected Cameroonians. Methods: HIV-infected Cameroonians aged 21 years or above were cross-sectionally recruited at the Yaoundé Central Hospital, a certified HIV care centre, and their anthropometry, body composition (impedancemetry), fasting blood glucose (FBG) and lipid levels, and insulin sensitivity (IS; short insulin tolerance test) were measured. Results: A total of 143 participants with various durations of HAART [treatment-naïve (n= 28), 1-13 months (n= 44), 14-33 months (n= 35) and 34-86 months (n= 36)] were recruited. They were mostly women (72%), and had a mean age of 39.5 (SD: 9.8) years. Half (52%) were using a stavudine-containing regimen. There was a significant trend towards a positive change in body mass index and waist-to-hip ratio with increasing duration of HAART (all P= 0.02). Systolic (P= 0.04) and diastolic (P= 0.03) blood pressure, total cholesterol (P= 0.01), prevalence of hypertension (P= 0.04) and hypercholesterolaemia (P= 0.007) were also significantly increased with HAART duration, whereas triglycerides, FBG and IS were unaffected. Clustering of metabolic disorders increased (P= 0.02 for ≥ 1 component of the metabolic syndrome and P= 0.09 for ≥ 2 components) with HAART duration. Conclusion: HAART duration is associated with obesity, fat distribution, blood pressure and cholesterol levels in HIV-infected Cameroonians, but does not appear to significantly affect glucose metabolism.

KW - Antiretroviral therapy

KW - Cardiovascular risk factors

KW - Human immunodeficiency virus

KW - Hyperglycaemia

KW - Insulin sensitivity

UR - http://www.scopus.com/inward/record.url?scp=84874296354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874296354&partnerID=8YFLogxK

U2 - 10.1016/j.diabet.2012.08.012

DO - 10.1016/j.diabet.2012.08.012

M3 - Article

C2 - 23153435

AN - SCOPUS:84874296354

VL - 39

SP - 71

EP - 77

JO - Diabetes and Metabolism

JF - Diabetes and Metabolism

SN - 1262-3636

IS - 1

ER -